Protection from rotavirus reinfection: 2-year prospective study.
about
Rotavirus vaccine for preventing diarrhoeaSang Froid in a time of trouble: is a vaccine against HIV possible?The relative frequencies of G serotypes of rotaviruses recovered from hospitalized children with diarrhea: A 10-year survey (1987-1996) in Japan with a review of globally collected data.Effects of maternal antibodies on protection and development of antibody responses to human rotavirus in gnotobiotic pigsSerotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children.Serum IgG mediates mucosal immunity against rotavirus infectionImmune response of children who develop persistent diarrhea following rotavirus infectionProtective effect of natural rotavirus infection in an Indian birth cohort.Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics.The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infectionsDevelopment of mucosal and systemic lymphoproliferative responses and protective immunity to human group A rotaviruses in a gnotobiotic pig modelRotavirus vaccines: an overview.Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.Rotavirus vaccines: recent developments and future considerations.Reinfection of adult cattle with rotavirus B during repeated outbreaks of epidemic diarrhea.Rotavirus vaccines: how they work or don't work.Role of coproantibody in clinical protection of children during reinfection with rotavirus.Group A rotavirus genotypes and the ongoing Brazilian experience: a review.A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings.Attenuation of a human rotavirus vaccine candidate did not correlate with mutations in the NSP4 protein gene.Immunodominance of the VP4 neutralization protein of rotavirus in protective natural infections of young children.Rotavirus vaccination and infection induce VP6-specific IgA responses.Homotypic immune response to primary infection with rotavirus serotype G1.Rotavirus vaccines: a perspective.Pediatric diarrhea.An age-structured epidemic model of rotavirus with vaccination.
P2860
Q24247507-E3B57D0A-5784-419C-B428-F59D4D87B3CDQ27487961-F64C1E11-2B0D-462E-A6EB-F84486843541Q30607768-409CCC23-5CEB-480B-8FAA-742B47EE4597Q33639021-FD1EF0BC-C19A-4FB9-BB77-9D083D35DF62Q33654939-F059339D-ACDB-496C-844B-D06275080AF3Q33821665-C07A4C9A-8AC6-48B4-97B1-ADE682478E6DQ33997869-25BE9336-7994-4502-BA88-4B79465FFFF4Q34203915-A0A8FF75-12CA-4B16-B146-F97E7E6570ECQ34441419-E24C4088-8611-4BB4-8FD7-FA7AEE436474Q34604662-624CDD6A-A95F-4702-925C-5669FDCDB973Q35226896-44431AF3-B01E-4B2A-9ABB-FD96C7F2320FQ35371774-FB018E18-905A-4248-A784-5F36614BB64EQ35860373-84363B5A-304C-4360-8543-AEDCA93AEF4AQ36850161-318485F7-BCE6-4B34-B0EF-62D292E08957Q37046059-08545CAC-65A0-4391-8A2B-3DCE42C40235Q37081817-A91BF57F-92C8-43D6-BCC0-D7AF8E25CCCEQ37123090-871C1F3E-64A7-443A-A6C7-2BE00A0BD085Q37369942-7F457B2F-6D6D-4986-B828-0D6CE88B1CFAQ37547272-BA29BBDC-EE06-43F7-9258-4BD575530BFDQ38281298-BFED5E9C-F5F8-4DC2-9C6E-0EB98DB61317Q39880710-6B1551A4-2DA9-4627-B037-635B4C088A91Q40043630-35962A3B-5255-477B-8BD0-77601D72A8BCQ40608783-4095571A-8EF6-480E-B95F-AA32403C4562Q41263499-291248B5-1F5B-4309-9334-9C7C981B0487Q41289871-7F693C59-A4DB-4333-B541-727CDCBB7E1AQ41699621-8931B236-1374-4D8D-9D79-368AE3C148DFQ51935057-54637BC2-641C-4253-B59D-1ED08984798F
P2860
Protection from rotavirus reinfection: 2-year prospective study.
description
1991 nî lūn-bûn
@nan
1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Protection from rotavirus reinfection: 2-year prospective study.
@ast
Protection from rotavirus reinfection: 2-year prospective study.
@en
Protection from rotavirus reinfection: 2-year prospective study.
@nl
type
label
Protection from rotavirus reinfection: 2-year prospective study.
@ast
Protection from rotavirus reinfection: 2-year prospective study.
@en
Protection from rotavirus reinfection: 2-year prospective study.
@nl
prefLabel
Protection from rotavirus reinfection: 2-year prospective study.
@ast
Protection from rotavirus reinfection: 2-year prospective study.
@en
Protection from rotavirus reinfection: 2-year prospective study.
@nl
P2093
P356
P1476
Protection from rotavirus reinfection: 2-year prospective study.
@en
P2093
P304
P356
10.1093/INFDIS/164.2.277
P407
P577
1991-08-01T00:00:00Z